Nexalin Technology develops transcranial electrical stimulation equipment for the treatment of anxiety, insomnia, and depression.
Nexalin Technology has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2025.
Nexalin Technology is headquartered in Houston, United States.
Nexalin Technology develops transcranial electrical stimulation equipment for the treatment of anxiety, insomnia, and depression.
Nexalin Technology is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nexalin Technology — Funding & Investors." VCBacked, May 5, 2025, https://www.vcbacked.co/company/nexalin-technology. Accessed August 13, 2026.
VCBacked. (2025). Nexalin Technology — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/nexalin-technology
{{cite web |title=Nexalin Technology — Funding & Investors |url=https://www.vcbacked.co/company/nexalin-technology |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated